Treatment of Early-Stage Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 182
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2011 AND VI 25 AND IP 2
Results: 16
1
2
Complementary Therapies, Herbs, and Other OTC Agents.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 195
- By:
- Publication type:
- Article
3
Adjuvant and Neoadjuvant Therapy for Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 192
- By:
- Publication type:
- Article
4
Intraperitoneal Chemotherapy for Advanced Epithelial Ovarian Cancer: Many Questions, Much Promise...
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 176
- By:
- Publication type:
- Article
5
Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 189
- By:
- Publication type:
- Article
6
Choose TREANDA for front-line treatment of CLL.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 103
- Publication type:
- Article
7
Vectibix (panitumumab) Injuction for IV Infusion.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 171
- Publication type:
- Article
8
Intraperitoneal Drug Delivery for Ovarian Cancer: Why, How, Who, What, and When?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 156
- By:
- Publication type:
- Article
9
Oncogenic BRAF: A new potential therapeutic target.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 112
- Publication type:
- Article
10
Alternative Approaches to Paying for Cancer Care.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 108
- By:
- Publication type:
- Article
11
Adjuvant Anthracyclines: Time for a Change of Heart?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 140
- By:
- Publication type:
- Article
12
Use of IP Chemotherapy in Ovarian Cancer: The Critical Questions.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 170
- By:
- Publication type:
- Article
13
Anthracyclines Are a Critical Component of Adjuvant Chemotherapy Regimens for High-Risk Early Breast Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 134
- By:
- Publication type:
- Article
14
Seeing Red: Anthracyclines for Breast Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 128
- By:
- Publication type:
- Article
15
Can We Abandon Anthracyclines for Early Breast Cancer Patients?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 115
- By:
- Publication type:
- Article
16
With Longer Survival Rates, AIDS Patients Face Elevated Cancer Risk.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 144
- Publication type:
- Article